You are here: Industry Insights > Fujifilm

News List

Fujifilm to seek approval for Avigan in Covid-19 after positive data pharmaceutical-technology
September 27, 2020
Japan’s Fujifilm Toyama Chemical plans to seek approval for its anti-viral drug Avigan (favipiravir) to treat patients with Covid-19, after obtaining positive results in Phase III clinical trial.
Novavax, FUJIFILM Initiate Large Scale Mfg. of COVID-19 Vax Candidate contractpharma
July 27, 2020
FUJIFILM to manufacture bulk drug substance for NVX-CoV2373 from its site in Morrisville, NC for Phase III trial.
Dr Reddy’s signs agreement with FUJIFILM and Global Response Aid for Avigan (favipiravir) expresspharma
July 02, 2020
Dr Reddy’s would have exclusive rights for development, selling and distribution of Avigan in India.
Fujifilm commits $928m to expand biologics facility in Denmark pharmaceutical-technology
June 11, 2020
Fujifilm expects the capital investment to double the Denmark site's existing drug substance manufacturing capacity.
FUJIFILM Investing $928M in Denmark CDMO Site contractpharma
June 10, 2020
Will double the site's current drug substance manufacturing capacity and will expand capabilities to include fill/finish.
Tonix and Fujifilm Enter COVID-19 Vax Deal contractpharma
June 09, 2020
Collaboration includes development of manufacturing processes and supply of clinical trial material to support Tonix’s development of TNX-1800.
Fujifilm says COVID-19 drug research may drag on into July expresspharma
June 08, 2020
“There is a possibility that clinical trials will continue in July,” a Fujifilm spokesman said, responding to a Nikkei report that any approval will be delayed until July or later, due to a lack of patients for trials.
Fujifilm shares fall after report Avigan not showing clear efficacy in some coronavirus trials expresspharma
May 21, 2020
The data reported to Japan’s health ministry by hospitals treating people showing mild or no symptoms raises doubts about whether the drug can be approved by the end of this month.
Production of Avigan® Tablet (favipiravir) accelerated for use against COVID-19 europeanpharmaceuticalreview
April 20, 2020
FUJIFILM intends to accelerate production of Avigan to 100,000 treatment courses per month by July and up to 300,000 by September 2020 to meet demand for possible use treating COVID-19.
Fujifilm boosts production capacity for potential Covid-19 drug Avigan pharmaceutical-technology
April 17, 2020
Japan’s Fujifilm has expanded manufacturing capacity to boost production of its influenza drug Avigan (favipiravir), being assessed to potentially treat Covid-19.

Previous page 1 2 3 4 5 Next page